Try it
Pharmacology · Chemotherapy: sirolimus compared with calcineurin inhibitors
Sample itemA renal transplant recipient with tacrolimus-related nephrotoxicity is switched to sirolimus. Which adverse effect is characteristic of sirolimus?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Hyperlipidaemia, mouth ulcers and delayed wound healing
Sirolimus inhibits mTOR, blocking IL-2 driven T cell proliferation. Its typical adverse effects are hyperlipidaemia, aphthous ulcers, delayed wound healing, proteinuria and pneumonitis, while it lacks the direct nephrotoxicity of calcineurin inhibitors. Gingival hyperplasia and hirsutism belong to cyclosporine.
Option by option
A. Hyperlipidaemia, mouth ulcers and delayed wound healing (correct)
Correct. Lipid disturbance, mouth ulcers and poor wound healing are typical of mTOR inhibition.
B. Tremor and new-onset diabetes
Tremor and new-onset diabetes are typical of tacrolimus.
C. Gingival hyperplasia and hirsutism
Gingival hyperplasia and hirsutism are typical of cyclosporine.
D. Marked nephrotoxicity with hyperkalaemia
Nephrotoxicity with hyperkalaemia is typical of calcineurin inhibitors.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?